nCoV Map

Booster dose of Pfizer/BioNTech in children shows good response
United States // 16 April, 2022
Clinical trial data showed good immune response after booster dose in children ages 5 to 11....
COVID-19
Valneva COVID-19 vaccine approved
United Kingdom // 15 April, 2022
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the Valneva vaccine for...
COVID-19
Vaccine Update - Vaccinations for children and issuance of vaccine passport begins
Vietnam // 15 April, 2022
Health authorities begin vaccinating children aged five to 11 years...
COVID-19
COVID-19 breath test authorised
United States // 15 April, 2022
The United States Food and Drug Administration (FDA) issued an emergency use authorisation (EUA) for a COVID-19 diagnostic test that uses breath...
COVID-19
First case of COVID-19 XE recombinant variant
Japan // 14 April, 2022
First in the country...
COVID-19
COVID-19 update for Africa, April
14 April, 2022
COVID-19 in Africa
COVID-19
XE and other Omicron recombinant variants
Australia // Belgium // Denmark // Finland // Netherlands // United Kingdom // 14 April, 2022
More Omicron recombinants identified...
COVID-19
WHO IHR Emergency Committee on COVID-19 11th meeting
14 April, 2022
The COVID-19 pandemic remains a Public Health Emergency of International Concern.....
COVID-19, General Articles
Mixed and recombinant COVID-19 variants in NSW
Australia // 13 April, 2022
Delta/Omicron recombinant and XE variants reported.....
COVID-19
Omicron BA.4 and BA.5 subvariants
Botswana // Denmark // Germany // South Africa // United Kingdom // 12 April, 2022
Two new Omicron subvariants, BA.4 and BA.5, have been reported by WHO and UK health authorities...
COVID-19
Inflammation from COVID-19 may be the cause of loss of smell
United States // 12 April, 2022
SARS-CoV-2 virus not directly responsible…
COVID-19
Omicron cases appear to be shorter in duration with reduced probability of hospitalisation than Delta cases, study
United Kingdom // 10 April, 2022
A study published in the Lancet...
COVID-19
Fluvoxamine and reduced COVID-19 hospitalisation, study
09 April, 2022
A systematic review and meta-analysis published on JAMA Network...
COVID-19
Risks of developing deep vein thrombosis, pulmonary embolism and bleeding after COVID-19, study
Sweden // 09 April, 2022
A study published in the BMJ...
COVID-19
FDA no longer authorises use of sotrovimab
United States // 08 April, 2022
In any US state and territory...
COVID-19
Protection by fourth dose of Pfizer vaccine, study
08 April, 2022
Rates of COVID-19 infection lowered...
COVID-19
Periodic booster dose of COVID-19 vaccine approved
Bahrain // 08 April, 2022
All vaccinated adults are eligible to take a dose of COVID-19 vaccine every nine months from...
COVID-19
New IMF strategy to manage the long-term risks of COVID-19
08 April, 2022
The International Monetary Fund released its Global Strategy for the management of COVID-19...

COVID-19
WHO: Low COVID-19 vaccination coverage in Africa
08 April, 2022
A low proportion of people in Africa are fully vaccinated...
COVID-19
WHO: Close to two-thirds of people in Africa exposed to COVID-19
08 April, 2022
COVID-19 infections in Africa are estimated to be 97 times higher than reported...
COVID-19

Quick Links

nCoV Map

LATEST NEWS (PREMIUM ACCESS)